IL6 and atherosclerosis: In a mouse model of atherosclerosis induced by a high-fat diet [29], oral administration of GRb1 was found to suppress levels of inflammatory factors such as IL-1β, IL-6, and TNF-α in serum, attenuating apoptosis associated with inflammatory activity.